In previous work we found that drugs such as nintedanib and pirfenidone, which have been used to treat IPF [62,63], elevate Rnd3 expression and thereby decrease RhoA activity [57]. The gene discussed is RHOA; the disease is idiopathic pulmonary fibrosis.